Nicholson acts to ensure that trusts and CCGs do not blacklist drugs approved by NICEBMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e5465 (Published 13 August 2012) Cite this as: BMJ 2012;345:e5465
- Ingrid Torjesen
The Department of Health for England is taking action against cash strapped primary care trusts that blacklist expensive drugs approved by the National Institute for Health and Clinical Excellence and thereby create a “postcode lottery.”
The NHS chief executive, David Nicholson, has told primary care trust clusters and the clinical commissioning groups that will replace them that they must publish, by 1 April 2013, details of which NICE recommended drugs are included in their formularies.
This information must be published online in a clear and simple format that can be easily understood by patients. And from April 2013 …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial